Farhad Sahebkar

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

Elizabeth A. Thiele, E. Martina Bebin, Hari Bhathal et al. · JAMA Neurology · 2020 · 262 citations · Full text

Medicine, Neurology, Pharmacology +14

Long‐term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open‐label extension trial

Elizabeth A. Thiele, E. Martina Bebin, Francis Filloux et al. · Epilepsia · 2021 · 104 citations · Full text

Medicine, Neurology, Pharmacology +8

A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment

Bola Tayo, Lesley Taylor, Farhad Sahebkar et al. · Clinical Pharmacokinetics · 2019 · 63 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6

Joyce Y. Wu, Hannah R. Cock, Orrin Devinsky et al. · Epilepsia · 2022 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program

Jerzy P. Szaflarski, Orrin Devinsky, Merrick Lopez et al. · Epilepsia · 2022 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15